440 related articles for article (PubMed ID: 9201294)
21. Acute lymphoblastic leukemia with the phenotype of a putative B-cell/T-cell bipotential precursor.
Lau LG; Tan LK; Koay ES; Ee MH; Tan SH; Liu TC
Am J Hematol; 2004 Oct; 77(2):156-60. PubMed ID: 15389907
[TBL] [Abstract][Full Text] [Related]
22. Immune response of post-transplant peripheral lymphocytes against the patient pre-B cell line, NAGL-1.
Kasai M; Akatsuka Y; Emi N; Taji H; Kohno A; Abe A; Tanimoto M; Kodera Y; Saito H
Int J Hematol; 1999 Feb; 69(2):112-8. PubMed ID: 10071461
[TBL] [Abstract][Full Text] [Related]
23. Therapy-related acute leukemia with mixed phenotype and t(9;22)(q32;q11.2): a case report and review of the literature.
Cho JH; Hur M; Moon HW; Yun YM; Ko YS; Kim WS; Lee MH
Hum Pathol; 2012 Apr; 43(4):605-9. PubMed ID: 22036054
[TBL] [Abstract][Full Text] [Related]
24. A phase I and pharmacodynamic study of fludarabine, carboplatin, and topotecan in patients with relapsed, refractory, or high-risk acute leukemia.
Cooper BW; Veal GJ; Radivoyevitch T; Tilby MJ; Meyerson HJ; Lazarus HM; Koc ON; Creger RJ; Pearson G; Nowell GM; Gosky D; Ingalls ST; Hoppel CL; Gerson SL
Clin Cancer Res; 2004 Oct; 10(20):6830-9. PubMed ID: 15501959
[TBL] [Abstract][Full Text] [Related]
25. Selective killing of malignant cells from leukemic patients by alkyl-lysophospholipid.
Verdonck LF; Witteveen EO; van Heugten HG; Rozemuller E; Rijksen G
Cancer Res; 1990 Jul; 50(13):4020-5. PubMed ID: 2354451
[TBL] [Abstract][Full Text] [Related]
26. Translocation (14;14)(q11;q32) with simultaneous involvement of the IGH and CEBPE genes in B-lineage acute lymphoblastic leukemia.
Han Y; Xue Y; Zhang J; Wu Y; Pan J; Wang Y; Shen J; Dai H; Bai S
Cancer Genet Cytogenet; 2008 Dec; 187(2):125-9. PubMed ID: 19027493
[TBL] [Abstract][Full Text] [Related]
27. [Effect of modified FLAG regimen therapy on 33 patients with relapsed/refractory leukemia].
Meng FY; Yang LJ; Xu B; Liu XL; Zheng WY; Zhang Y; Huang F; Sun J; Liu QF
Ai Zheng; 2003 Dec; 22(12):1330-3. PubMed ID: 14693062
[TBL] [Abstract][Full Text] [Related]
28. [DBMP-85 was effective at diagnosis and LVP was effective at relapse in a case of acute mixed leukemia].
Endo M; Kanemaru M; Kubo Y; Kouda K; Sakurai T; Iizuka Y; Takeuchi J; Horikoshi A; Ohshima T
Rinsho Ketsueki; 1990 Mar; 31(3):320-4. PubMed ID: 2366335
[TBL] [Abstract][Full Text] [Related]
29. [Acute appendicitis during bone marrow suppression following chemotherapy for acute leukemia; report of three cases].
Kajiwara R; Goto H; Yokosuka T; Yanagimachi M; Kuroki F; Fujii H; Takahashi H; Yokota S
Rinsho Ketsueki; 2007 Mar; 48(3):223-8. PubMed ID: 17441480
[TBL] [Abstract][Full Text] [Related]
30. CD56+CD7+ stem cell leukemia/lymphoma with D2-Jdelta1 rearrangement.
Yoshida T; Kimura N; Sawada H; Suematsu E; Nagano M; Akiyoshi T; Motomura S; Kikuchi M; Nishimura J; Tamura K
Intern Med; 1999 Jul; 38(7):547-55. PubMed ID: 10435360
[TBL] [Abstract][Full Text] [Related]
31. Phase I and pharmacokinetic study of flavopiridol followed by 1-beta-D-arabinofuranosylcytosine and mitoxantrone in relapsed and refractory adult acute leukemias.
Karp JE; Passaniti A; Gojo I; Kaufmann S; Bible K; Garimella TS; Greer J; Briel J; Smith BD; Gore SD; Tidwell ML; Ross DD; Wright JJ; Colevas AD; Bauer KS
Clin Cancer Res; 2005 Dec; 11(23):8403-12. PubMed ID: 16322302
[TBL] [Abstract][Full Text] [Related]
32. Lineage switch and multilineage involvement in two cases of pH chromosome-positive acute leukemia: evidence for a stem cell disease.
Cuneo A; Balboni M; Piva N; Carli MG; Tomasi P; Previati R; Negrini M; Scapoli G; Spanedda R; Castoldi G
Haematologica; 1994; 79(1):76-82. PubMed ID: 15378954
[TBL] [Abstract][Full Text] [Related]
33. Poor outcome for children and adolescents with progressive disease or relapse of lymphoblastic lymphoma: a report from the berlin-frankfurt-muenster group.
Burkhardt B; Reiter A; Landmann E; Lang P; Lassay L; Dickerhoff R; Lakomek M; Henze G; von Stackelberg A
J Clin Oncol; 2009 Jul; 27(20):3363-9. PubMed ID: 19433688
[TBL] [Abstract][Full Text] [Related]
34. [Cytomorphology of acute mixed leukemia].
Sucić M; Batinić D; Zadro R; Mrsić S; Labar B
Acta Med Croatica; 2008 Oct; 62(4):379-85. PubMed ID: 19205415
[TBL] [Abstract][Full Text] [Related]
35. Clinical significance of P-glycoprotein expression and function for response to induction chemotherapy, relapse rate and overall survival in acute leukemia.
Wuchter C; Leonid K; Ruppert V; Schrappe M; Büchner T; Schoch C; Haferlach T; Harbott J; Ratei R; Dörken B; Ludwig WD
Haematologica; 2000 Jul; 85(7):711-21. PubMed ID: 10897123
[TBL] [Abstract][Full Text] [Related]
36. Expression of CD10, CD19 and CD34 markers in bone marrow samples of children with precursor B-cell acute lymphoblastic leukemia in clinical and hematological remission.
Cáp J; Babusíková O; Kaiserová E; Jamárik M
Neoplasma; 1998; 45(4):231-6. PubMed ID: 9890666
[TBL] [Abstract][Full Text] [Related]
37. Long-term outcome in children with relapsed ALL by risk-stratified salvage therapy: results of trial acute lymphoblastic leukemia-relapse study of the Berlin-Frankfurt-Münster Group 87.
Einsiedel HG; von Stackelberg A; Hartmann R; Fengler R; Schrappe M; Janka-Schaub G; Mann G; Hählen K; Göbel U; Klingebiel T; Ludwig WD; Henze G
J Clin Oncol; 2005 Nov; 23(31):7942-50. PubMed ID: 16258094
[TBL] [Abstract][Full Text] [Related]
38. Fludarabine, cytarabine, G-CSF and idarubicin (FLAG-IDA) for the treatment of relapsed or poor risk childhood acute leukemia.
Yalman N; Sarper N; Devecioğlu O; Anak S; Eryilmaz E; Can M; Yenilmez H; Ağaoğlu L; Gedikoğlu G
Turk J Pediatr; 2000; 42(3):198-204. PubMed ID: 11105617
[TBL] [Abstract][Full Text] [Related]
39. [Acute lymphoblastic leukemia with L1 morphology arising during treatment for ALL-L3 in a child with AIDS].
Fernández-Teijeiro A; Piñán MA; Cardenal I; Astigarraga I; Navajas A
Sangre (Barc); 1996 Jun; 41(3):245-8. PubMed ID: 8755213
[TBL] [Abstract][Full Text] [Related]
40. [Response to treatment and survival of adults with acute leukemia classified with immunophenotyping and cytochemistry].
Sobrevilla Calvo P; Acosta Barreda A; López Karpóvitch X; Salles Manuel MT; Reynoso Gómez E; Guarner Lans J
Rev Invest Clin; 1994; 46(5):399-406. PubMed ID: 7839021
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
